Eclitasertib (Synonyms: DNL-758; SAR-443122) |
| Katalog-Nr.GC63470 |
Eclitasertib (DNL-758) ist ein potenter Hemmer der Rezeptor-interagierenden Proteinkinase 1 (RIPK1) mit einem IC50 von <1 μM (aus Patent WO2017136727A2, Beispiel 42).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2125450-76-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Eclitasertib (DNL-758) is a potent receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 of <1 µμ (From patent WO2017136727A2, example 42)[1].
[1]. Anthony A. ESTRADA, et al. Compounds, compositions and methods. WO2017136727A2.
Average Rating: 5 (Based on Reviews and 12 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *